These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 22634497)
1. EMT in breast cancer stem cell generation. Ansieau S Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497 [TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell: fundamental experimental pathological concepts and updates. Islam F; Qiao B; Smith RA; Gopalan V; Lam AK Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759 [TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Mallini P; Lennard T; Kirby J; Meeson A Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504 [TBL] [Abstract][Full Text] [Related]
4. Inflammation linking EMT and cancer stem cells. Zhou C; Liu J; Tang Y; Liang X Oral Oncol; 2012 Nov; 48(11):1068-75. PubMed ID: 22766510 [TBL] [Abstract][Full Text] [Related]
7. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Xia H; Hui KM Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem cells: obstacles to therapy. Smalley M; Piggott L; Clarkson R Cancer Lett; 2013 Sep; 338(1):57-62. PubMed ID: 22554712 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance. Pinto CA; Widodo E; Waltham M; Thompson EW Cancer Lett; 2013 Nov; 341(1):56-62. PubMed ID: 23830804 [TBL] [Abstract][Full Text] [Related]
11. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120 [TBL] [Abstract][Full Text] [Related]
12. [New aspects of the pathogenesis and classification of basal-like breast carcinoma]. Gorelik MZ; Andreeva IuIu; Zavalishina LÉ Arkh Patol; 2013; 75(4):48-53. PubMed ID: 24313193 [TBL] [Abstract][Full Text] [Related]
13. Primary culture of breast cancer: a model system for epithelial-mesenchymal transition and cancer stem cells. Nishikata T; Ishikawa M; Matsuyama T; Takamatsu K; Fukuhara T; Konishi Y Anticancer Res; 2013 Jul; 33(7):2867-73. PubMed ID: 23780972 [TBL] [Abstract][Full Text] [Related]
14. EMT as the ultimate survival mechanism of cancer cells. Tiwari N; Gheldof A; Tatari M; Christofori G Semin Cancer Biol; 2012 Jun; 22(3):194-207. PubMed ID: 22406545 [TBL] [Abstract][Full Text] [Related]
15. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis]. Yoshida GJ; Saya H Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063 [TBL] [Abstract][Full Text] [Related]
16. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Fantozzi A; Gruber DC; Pisarsky L; Heck C; Kunita A; Yilmaz M; Meyer-Schaller N; Cornille K; Hopfer U; Bentires-Alj M; Christofori G Cancer Res; 2014 Mar; 74(5):1566-75. PubMed ID: 24413534 [TBL] [Abstract][Full Text] [Related]
19. Essentials of circulating tumor cells for clinical research and practice. Liberko M; Kolostova K; Bobek V Crit Rev Oncol Hematol; 2013 Nov; 88(2):338-56. PubMed ID: 23830807 [TBL] [Abstract][Full Text] [Related]
20. Epithelial plasticity, cancer stem cells and bone metastasis formation. van der Pluijm G Bone; 2011 Jan; 48(1):37-43. PubMed ID: 20670698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]